Published in J Exp Med on August 17, 1998
Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med (1999) 2.11
Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction. Ann Rheum Dis (1999) 1.37
Lymph node germinal centers form in the absence of follicular dendritic cell networks. J Exp Med (1999) 1.16
Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis. J Virol (2000) 1.03
Splenic CD19-CD35+B220+ cells function as an inducer of follicular dendritic cell network formation. Blood (2007) 0.93
Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. Mol Cell Biol (2006) 0.90
Parenchymal cell TNF receptors contribute to inflammatory cell recruitment and respiratory failure in Pneumocystis carinii-induced pneumonia. J Immunol (2008) 0.90
TNFα-dependent development of lymphoid tissue in the absence of RORγt⁺ lymphoid tissue inducer cells. Mucosal Immunol (2013) 0.83
Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction. Infect Immun (2002) 0.82
Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation. Vascul Pharmacol (2016) 0.80
An ENU-induced mutation in the lymphotoxin alpha gene impairs organogenesis of lymphoid tissues in C57BL/6 mice. Biochem Biophys Res Commun (2008) 0.79
Severe thymic atrophy in a mouse model of skin inflammation accounts for impaired TNFR1 signaling. PLoS One (2012) 0.78
Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering. Front Immunol (2017) 0.75
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J (1991) 8.31
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (1994) 7.10
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature (1993) 7.10
A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell (1988) 5.42
Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell (1996) 4.55
Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity (1997) 4.10
Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity (1997) 3.99
Two tumour necrosis factor receptors: structure and function. Trends Cell Biol (1995) 3.67
Cells in the marginal zone of the spleen. Int Rev Cytol (1992) 3.27
Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science (1996) 3.24
Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med (1996) 2.93
Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci U S A (1996) 2.83
Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell (1993) 2.74
A lymphotoxin-beta-specific receptor. Science (1994) 2.73
Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med (1989) 2.63
Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci U S A (1997) 2.37
The ligands and receptors of the lymphotoxin system. Curr Top Microbiol Immunol (1995) 2.32
A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics (1988) 2.13
Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med (1996) 1.93
Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol (1988) 1.86
Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int Immunol (1996) 1.83
Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol (1997) 1.80
Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. Proc Natl Acad Sci U S A (1996) 1.71
Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc Natl Acad Sci U S A (1997) 1.66
Marginal zone macrophages in the mouse spleen identified by a monoclonal antibody. Anatomical correlation with a B cell subpopulation. J Histochem Cytochem (1985) 1.57
The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures. Immunology (1979) 1.43
LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma. J Immunol (1993) 1.21
Sialoadhesin binds preferentially to cells of the granulocytic lineage. J Clin Invest (1995) 1.19
Mutant mice without B lymphocyte follicles. J Exp Med (1996) 1.18
A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol (1997) 1.18
Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node. Proc Natl Acad Sci U S A (1997) 1.14
Distinct roles of lymphotoxin alpha and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells. J Exp Med (1997) 0.99
Transgenic expression of lymphotoxin restores lymph nodes to lymphotoxin-alpha-deficient mice. J Immunol (1997) 0.99
Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp. J Exp Med (1998) 0.99
Cloning and expression analysis of the murine lymphotoxin beta gene. Proc Natl Acad Sci U S A (1995) 0.98
Tumour necrosis factors in immune regulation: everything that's interesting is...new! Cytokine Growth Factor Rev (1996) 0.95
Lymphotoxins: from cytotoxicity to lymphoid organogenesis. Proc Natl Acad Sci U S A (1997) 0.89
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell (1987) 15.79
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J (1991) 8.31
Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity (1999) 7.34
TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell (2000) 6.07
The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell (1995) 5.08
Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med (1999) 4.41
CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci (2001) 4.12
NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell (2000) 3.60
The human beta-globin gene contains a downstream developmental specific enhancer. Nucleic Acids Res (1987) 3.54
Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med (1998) 3.20
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol (1997) 2.35
Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes (1997) 2.10
Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med (2000) 2.00
Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest (1995) 1.96
Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J (2001) 1.93
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med (1997) 1.92
Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1995) 1.76
Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc Natl Acad Sci U S A (1997) 1.66
Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol (1998) 1.62
In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol (1997) 1.53
DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J Immunol (1997) 1.52
Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem (2000) 1.49
Transgenic mice expressing the human inducible Hsp70 have hippocampal neurons resistant to ischemic injury. Cell Stress Chaperones (1997) 1.43
Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol (1997) 1.42
The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur J Immunol (1995) 1.39
Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction. Ann Rheum Dis (1999) 1.37
Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol (2000) 1.34
Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res (2000) 1.32
Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm (1997) 1.30
Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J Immunol (1993) 1.27
The maintenance of methylation-free islands in transgenic mice. Nucleic Acids Res (1986) 1.26
Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell Immunol (2000) 1.25
Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J Rheumatol (2000) 1.23
Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology (1994) 1.19
Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur J Immunol (2000) 1.19
The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med (1998) 1.19
A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol (1997) 1.18
The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Cytokine (1995) 1.17
Differential regulation of a Thy-1 gene in transgenic mice. Proc Natl Acad Sci U S A (1987) 1.14
TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J Neuroimmunol (1997) 1.13
Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression. Clin Exp Immunol (1999) 1.13
Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ (2011) 1.13
[Ileovesical fistula in Crohn's disease (author's transl)]. MMW Munch Med Wochenschr (1979) 1.08
TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis. Eur J Immunol (1999) 1.08
Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol (2006) 1.07
A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R. J Exp Med (1998) 1.06
Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-alpha. J Biol Chem (1999) 1.03
Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm (1996) 1.02
Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. J Immunol (1999) 1.02
Cutting edge: antilisterial activity of CD8+ T cells derived from TNF-deficient and TNF/perforin double-deficient mice. J Immunol (2000) 1.02
TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models. J Clin Invest (2001) 1.01
MUGEN mouse database; animal models of human immunological diseases. Nucleic Acids Res (2007) 0.96
Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice. J Leukoc Biol (1996) 0.95
Tumour necrosis factors in immune regulation: everything that's interesting is...new! Cytokine Growth Factor Rev (1996) 0.95
Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice. Arthritis Rheum (2001) 0.95
The role of TNF-alpha during Wallerian degeneration. J Neuroimmunol (2000) 0.94
A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. Eur J Immunol (1999) 0.94
Serum total IgE levels in a representative sample of a Greek population. I. Correlation with age, sex, and skin reactivity to common aeroallergens. Allergy (1993) 0.91
The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors (1993) 0.90
Fibroblast biology. Synovial fibroblasts in rheumatoid arthritis: leading role or chorus line? Arthritis Res (2000) 0.89
Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. Clin Exp Immunol (1998) 0.88
Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis. Ann Rheum Dis (2007) 0.86
Alpha-amanitin insensitive transcription of the human epsilon-globin gene. Nucleic Acids Res (1985) 0.86
Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice. Eur J Haematol (1999) 0.86
Prion propagation in mice lacking central nervous system NF-kappaB signalling. J Gen Virol (2008) 0.84
Neurobehavioral alterations in developing transgenic mice expressing TNF-alpha in the brain. Brain Behav Immun (1996) 0.84
Defective CD4T cell priming and resistance to experimental autoimmune encephalomyelitis in TNF-deficient mice due to innate immune hypo-responsiveness. J Neuroimmunol (2001) 0.84
Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha. Physiol Behav (1998) 0.83
T cell independent Thy-1 allo-antibody response with the use of transgenic mice. J Immunol (1986) 0.83
Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide. J Biol Chem (2000) 0.82
Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD. Mucosal Immunol (2010) 0.81
Effect of NGF antibodies on mast cell distribution, histamine and substance P levels in the knee joint of TNF-arthritic transgenic mice. Rheumatol Int (1995) 0.81
Expression of adult and tadpole specific globin genes from Xenopus laevis in transgenic mice. Nucleic Acids Res (1991) 0.81
Primary malignant fibrous histiocytoma of the kidney: report of a case. J Urol (1987) 0.80
Osteochondroma in a lioness. J Am Vet Med Assoc (1976) 0.80
The regulation of expression of human beta-globin genes. Prog Clin Biol Res (1987) 0.80
[Diverticula of the bladder: pathogenesis, clinical course and treatment (author's transl)]. Urologe A (1974) 0.79
Autoimmunity and rheumatoid arthritis. Autoimmun Rev (2004) 0.79
Transgenic models of TNF induced demyelination. Adv Exp Med Biol (1999) 0.78
Operational criteria for selecting a cDNA microarray data normalization algorithm. Oncol Rep (2006) 0.78
Ectopic expression of Thy-1 in the kidneys of transgenic mice induces functional and proliferative abnormalities. Cell (1988) 0.77